ArticleBreast cancer (Dove Medical Press)2023

CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1.

Xudong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.